Friday, October 24, 2025

Latest

Psyched Wellness Latest Firm To Conduct Bought Deal Financing

Psyched Wellness (CSE: PSYC) is the latest psychedelics-focused firm to announce a bought deal financing, with the company this evening announcing a financing for $3.0 million. The financing is to be lead by Canaccord Genuity Corp of the behalf of a syndicate of underwriters.

The financing will see units of the company sold at a price of $0.31 per unit, with each unit containing one common share and one common share purchase warrant. Each warrant is valid for a period of three years from the date of issuance, with an exercise price of $0.43 per share.

Warrants issued under the offering are subject to an acceleration clause in the event that the equity trades above $0.70 for a period of five days on a volume weighted basis.

Proceeds from the financing are to be used to fully fund the pre-clinical trials of the firms Amanita Muscaria extract, and to continue the scientific research of the extract and its potential health benefits.

The financing is anticipated to close by February 12, 2021.

Psyched Wellness last traded at $0.36 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Psyched Wellness Submits Trademark For Amanita Muscaria Extract

Psyched Wellness (CSE: PSYC) is looking to build up its portfolio of intellectual property. The...

Thursday, January 21, 2021, 07:01:48 AM

Compass Pathways Leader Of Investment Climate For Psychedelic Plays – The Daily Dive feat Jeff Stevens

Today on the Daily Dive, Jeff Stevens returns to the show to sit down with...

Wednesday, December 30, 2020, 01:30:00 PM

Psyched Wellness Moves To Next Stage Of Pre-Clinical Trials With Mushroom Extract

Psyched Wellness (CSE: PSYC) continues to execute on its strategy as it pertains to the...

Thursday, October 7, 2021, 08:21:06 AM

Psyched Wellness Successfully Extracts Psychedelic Mushroom

Psyched Wellness (CSE: PSYC) has successfully completed its first extraction of the amanita muscaria mushroom....

Tuesday, December 15, 2020, 07:23:08 AM

Psyched Wellness Signs Two Year Supply Agreement For Amanita Muscaria

Psyched Wellness (CSE: PSYC) this morning had a brief announcement. Within, the company revealed that...

Tuesday, May 4, 2021, 08:36:07 AM